Off-target binding of an anti-amyloid beta monoclonal antibody to platelet factor 4 causes acute and chronic toxicity in cynomolgus monkeys
ABT-736 is a humanized monoclonal antibody generated to target a specific conformation of the amyloid-beta (Aβ) protein oligomer. Development of ABT-736 for Alzheimer’s disease was discontinued due to severe adverse effects (AEs) observed in cynomolgus monkey toxicity studies. The acute nature of AE...
Main Authors: | Lise I. Loberg, Meha Chhaya, Alexander Ibraghimov, Edit Tarcsa, Andreas Striebinger, Andreas Popp, Lili Huang, Frank Oellien, Stefan Barghorn |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2021-01-01
|
Series: | mAbs |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/19420862.2021.1887628 |
Similar Items
-
Highly sensitive detection of antibody nonspecific interactions using flow cytometry
by: Emily K. Makowski, et al.
Published: (2021-01-01) -
Toward Drug-Like Multispecific Antibodies by Design
by: Manali S. Sawant, et al.
Published: (2020-10-01) -
Physiologically Based Modeling to Predict Monoclonal Antibody Pharmacokinetics in Humans from in vitro Physiochemical Properties
by: Shihao Hu, et al.
Published: (2022-12-01) -
Polyvalent Snake Antivenoms: Production Strategy and Their Therapeutic Benefits
by: Kavi Ratanabanangkoon
Published: (2023-08-01) -
Human thymopoiesis produces polyspecific CD8+ α/β T cells responding to multiple viral antigens
by: Valentin Quiniou, et al.
Published: (2023-03-01)